Researchers at Gunma University have identified a compact genetic switch that could revolutionize the treatment of drug-resistant epilepsy. The discovery, published in Molecular Therapy, offers new avenues for addressing this debilitating condition.
A novel gene promoter called cmGAD67 shows promise for treating drug-resistant epilepsy by selectively stimulating inhibitory neurons. The study found that the promoter drove strong and highly selective gene expression in specific brain regions, reducing abnormal electrical activity and seizures.
Researchers find crab shell waste alters microbial communities on biodegradable plastics, reducing breakdown rate. The effect persists even without direct contact, suggesting biochemical compounds released from crab shells trigger changes in the plastisphere.